Laura A Kaplan, MD | |
385 Main St S, Southbury, CT 06488-4240 | |
(203) 264-7999 | |
Not Available |
Full Name | Laura A Kaplan |
---|---|
Gender | Female |
Speciality | Diagnostic Radiology |
Experience | 16 Years |
Location | 385 Main St S, Southbury, Connecticut |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356509269 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 51189 (Connecticut) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Saint Mary's Hospital | Waterbury, CT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Diagnostic Imaging Associates Llc | 0143127241 | 11 |
Diagnostic Imaging Of Southbury | 0143127548 | 17 |
Prospect Diagnostic Imaging | 0244137214 | 12 |
Naugatuck Valley Radiological Associates Pc | 5092600189 | 14 |
News Archive
A randomized controlled study published in the current issue of Psychotherapy and Psychosomatics has investigated the role of a special form of meditation (mindfulness) in Chronic pain.
People with serious mental illnesses are significantly more likely to experience injuries than the general population, US study results show.
As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to ravage the world, scientists are frantically searching for a vaccine or new drug that will effectively counter the lethal effects of the virus that leads to COVID-19 disease.
Biogen Idec today announced it has strengthened MS ActiveSource, its industry-leading suite of services for people with multiple sclerosis (MS), with the addition of new resources and support programs.
BioCryst Pharmaceuticals, Inc. announced that it received a preliminary comment letter from the U.S. Food & Drug Administration that outlines a pathway by which BioCryst could file a New Drug Application seeking regulatory approval of intravenous (i.v.) peramivir.
› Verified 2 days ago
Entity Name | Jefferson Radiology Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396795951 PECOS PAC ID: 8729982525 Enrollment ID: O20031124000161 |
News Archive
A randomized controlled study published in the current issue of Psychotherapy and Psychosomatics has investigated the role of a special form of meditation (mindfulness) in Chronic pain.
People with serious mental illnesses are significantly more likely to experience injuries than the general population, US study results show.
As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to ravage the world, scientists are frantically searching for a vaccine or new drug that will effectively counter the lethal effects of the virus that leads to COVID-19 disease.
Biogen Idec today announced it has strengthened MS ActiveSource, its industry-leading suite of services for people with multiple sclerosis (MS), with the addition of new resources and support programs.
BioCryst Pharmaceuticals, Inc. announced that it received a preliminary comment letter from the U.S. Food & Drug Administration that outlines a pathway by which BioCryst could file a New Drug Application seeking regulatory approval of intravenous (i.v.) peramivir.
› Verified 2 days ago
Entity Name | Diagnostic Imaging Of Southbury |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245252824 PECOS PAC ID: 0143127548 Enrollment ID: O20031215000523 |
News Archive
A randomized controlled study published in the current issue of Psychotherapy and Psychosomatics has investigated the role of a special form of meditation (mindfulness) in Chronic pain.
People with serious mental illnesses are significantly more likely to experience injuries than the general population, US study results show.
As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to ravage the world, scientists are frantically searching for a vaccine or new drug that will effectively counter the lethal effects of the virus that leads to COVID-19 disease.
Biogen Idec today announced it has strengthened MS ActiveSource, its industry-leading suite of services for people with multiple sclerosis (MS), with the addition of new resources and support programs.
BioCryst Pharmaceuticals, Inc. announced that it received a preliminary comment letter from the U.S. Food & Drug Administration that outlines a pathway by which BioCryst could file a New Drug Application seeking regulatory approval of intravenous (i.v.) peramivir.
› Verified 2 days ago
Entity Name | Diagnostic Imaging Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336161918 PECOS PAC ID: 0143127241 Enrollment ID: O20031217000292 |
News Archive
A randomized controlled study published in the current issue of Psychotherapy and Psychosomatics has investigated the role of a special form of meditation (mindfulness) in Chronic pain.
People with serious mental illnesses are significantly more likely to experience injuries than the general population, US study results show.
As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to ravage the world, scientists are frantically searching for a vaccine or new drug that will effectively counter the lethal effects of the virus that leads to COVID-19 disease.
Biogen Idec today announced it has strengthened MS ActiveSource, its industry-leading suite of services for people with multiple sclerosis (MS), with the addition of new resources and support programs.
BioCryst Pharmaceuticals, Inc. announced that it received a preliminary comment letter from the U.S. Food & Drug Administration that outlines a pathway by which BioCryst could file a New Drug Application seeking regulatory approval of intravenous (i.v.) peramivir.
› Verified 2 days ago
Entity Name | Prospect Diagnostic Imaging |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154343739 PECOS PAC ID: 0244137214 Enrollment ID: O20031217000697 |
News Archive
A randomized controlled study published in the current issue of Psychotherapy and Psychosomatics has investigated the role of a special form of meditation (mindfulness) in Chronic pain.
People with serious mental illnesses are significantly more likely to experience injuries than the general population, US study results show.
As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to ravage the world, scientists are frantically searching for a vaccine or new drug that will effectively counter the lethal effects of the virus that leads to COVID-19 disease.
Biogen Idec today announced it has strengthened MS ActiveSource, its industry-leading suite of services for people with multiple sclerosis (MS), with the addition of new resources and support programs.
BioCryst Pharmaceuticals, Inc. announced that it received a preliminary comment letter from the U.S. Food & Drug Administration that outlines a pathway by which BioCryst could file a New Drug Application seeking regulatory approval of intravenous (i.v.) peramivir.
› Verified 2 days ago
Entity Name | Naugatuck Valley Mri Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1134141716 PECOS PAC ID: 2668367756 Enrollment ID: O20040218000127 |
News Archive
A randomized controlled study published in the current issue of Psychotherapy and Psychosomatics has investigated the role of a special form of meditation (mindfulness) in Chronic pain.
People with serious mental illnesses are significantly more likely to experience injuries than the general population, US study results show.
As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to ravage the world, scientists are frantically searching for a vaccine or new drug that will effectively counter the lethal effects of the virus that leads to COVID-19 disease.
Biogen Idec today announced it has strengthened MS ActiveSource, its industry-leading suite of services for people with multiple sclerosis (MS), with the addition of new resources and support programs.
BioCryst Pharmaceuticals, Inc. announced that it received a preliminary comment letter from the U.S. Food & Drug Administration that outlines a pathway by which BioCryst could file a New Drug Application seeking regulatory approval of intravenous (i.v.) peramivir.
› Verified 2 days ago
Entity Name | Naugatuck Valley Radiological Associates Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1114949799 PECOS PAC ID: 5092600189 Enrollment ID: O20040218000142 |
News Archive
A randomized controlled study published in the current issue of Psychotherapy and Psychosomatics has investigated the role of a special form of meditation (mindfulness) in Chronic pain.
People with serious mental illnesses are significantly more likely to experience injuries than the general population, US study results show.
As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to ravage the world, scientists are frantically searching for a vaccine or new drug that will effectively counter the lethal effects of the virus that leads to COVID-19 disease.
Biogen Idec today announced it has strengthened MS ActiveSource, its industry-leading suite of services for people with multiple sclerosis (MS), with the addition of new resources and support programs.
BioCryst Pharmaceuticals, Inc. announced that it received a preliminary comment letter from the U.S. Food & Drug Administration that outlines a pathway by which BioCryst could file a New Drug Application seeking regulatory approval of intravenous (i.v.) peramivir.
› Verified 2 days ago
Entity Name | Connecticut Imaging Partners Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740315761 PECOS PAC ID: 4183649098 Enrollment ID: O20051011000041 |
News Archive
A randomized controlled study published in the current issue of Psychotherapy and Psychosomatics has investigated the role of a special form of meditation (mindfulness) in Chronic pain.
People with serious mental illnesses are significantly more likely to experience injuries than the general population, US study results show.
As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to ravage the world, scientists are frantically searching for a vaccine or new drug that will effectively counter the lethal effects of the virus that leads to COVID-19 disease.
Biogen Idec today announced it has strengthened MS ActiveSource, its industry-leading suite of services for people with multiple sclerosis (MS), with the addition of new resources and support programs.
BioCryst Pharmaceuticals, Inc. announced that it received a preliminary comment letter from the U.S. Food & Drug Administration that outlines a pathway by which BioCryst could file a New Drug Application seeking regulatory approval of intravenous (i.v.) peramivir.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Laura A Kaplan, MD 385 Main St S, Southbury, CT 06488-4240 Ph: (203) 267-5114 | Laura A Kaplan, MD 385 Main St S, Southbury, CT 06488-4240 Ph: (203) 264-7999 |
News Archive
A randomized controlled study published in the current issue of Psychotherapy and Psychosomatics has investigated the role of a special form of meditation (mindfulness) in Chronic pain.
People with serious mental illnesses are significantly more likely to experience injuries than the general population, US study results show.
As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to ravage the world, scientists are frantically searching for a vaccine or new drug that will effectively counter the lethal effects of the virus that leads to COVID-19 disease.
Biogen Idec today announced it has strengthened MS ActiveSource, its industry-leading suite of services for people with multiple sclerosis (MS), with the addition of new resources and support programs.
BioCryst Pharmaceuticals, Inc. announced that it received a preliminary comment letter from the U.S. Food & Drug Administration that outlines a pathway by which BioCryst could file a New Drug Application seeking regulatory approval of intravenous (i.v.) peramivir.
› Verified 2 days ago
Dr. George Jeffrey Gavern, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: Nvra Business Office, 385 Main St South, Southbury, CT 06488 Phone: 203-264-7999 Fax: 203-264-7477 | |
Matthew Bushey, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 385 Main St South, Union Square, Southbury, CT 06488 Phone: 203-264-7999 Fax: 203-264-7477 | |
Michael Malin, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 385 Main St S, Union Square, Southbury, CT 06488 Phone: 203-264-7999 Fax: 203-264-7477 | |
Robert Gumbardo, MD Radiology Medicare: Medicare Enrolled Practice Location: 385 Main St South, Union Square, Southbury, CT 06488 Phone: 203-264-7999 Fax: 203-264-7477 | |
Mahadevan Shetty, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 385 Main St S,, C/o Nvra Union Square Bldg#1, Southbury, CT 06488 Phone: 203-264-7999 Fax: 203-264-7477 | |
Gregory Gersten, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 385 Main St S, Union Square, Southbury, CT 06488 Phone: 203-264-7999 Fax: 203-264-7477 |